Purchases and Sales Made in Q3 2024 in Zentalis Pharmaceuticals, Inc. (ZNTL)
This table provides information about the institutional ownership of Zentalis Pharmaceuticals, Inc. (ZNTL) during Q3 2024. The information is specifically focused on institutions that hold shares of Zentalis Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 15, 2024
Q3 2024
|
Y Intercept (Hong Kong) LTD
|
SELL
|
- |
-91.6K- 88.16% |
$266K - $419K
|
12.3K
$36.8K
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-105K- 15.83% |
$304K - $479K
|
557K
$1.67M
|
|
Nov 07, 2024
Q3 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-121K- 19.31% |
$351K - $553K
|
506K
$1.51M
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-144K- 13.66% |
$417K - $657K
|
909K
$2.72M
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-339K- 17.39% |
$984K - $1.55M
|
1.61M
$4.82M
|
|
Nov 14, 2024
Q3 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-462K- 30.44% |
$1.34M - $2.11M
|
1.06M
$3.16M
|
|
Nov 13, 2024
Q3 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-1.04M- 18.43% |
$3.02M - $4.76M
|
4.61M
$13.8M
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.79M- 39.65% |
$5.18M - $8.16M
|
2.72M
$8.13M
|
|
Nov 14, 2024
Q3 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.81M- 59.16% |
$5.24M - $8.25M
|
1.25M
$3.73M
|